99 related articles for article (PubMed ID: 26905802)
1. Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.
Gómara MJ; Sánchez-Merino V; Paús A; Merino-Mansilla A; Gatell JM; Yuste E; Haro I
Biochim Biophys Acta; 2016 Jun; 1860(6):1139-48. PubMed ID: 26905802
[TBL] [Abstract][Full Text] [Related]
2. A cyclic GB virus C derived peptide with anti-HIV-1 activity targets the fusion peptide of HIV-1.
Galatola R; Vasconcelos A; Pérez Y; Cruz A; Pujol M; Alsina MA; Gómara MJ; Haro I
Eur J Med Chem; 2014 Oct; 86():589-604. PubMed ID: 25218908
[TBL] [Abstract][Full Text] [Related]
3. Structural Study of a New HIV-1 Entry Inhibitor and Interaction with the HIV-1 Fusion Peptide in Dodecylphosphocholine Micelles.
Pérez Y; Gómara MJ; Yuste E; Gómez-Gutierrez P; Pérez JJ; Haro I
Chemistry; 2017 Aug; 23(48):11703-11713. PubMed ID: 28677862
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds.
Gómara MJ; Galatola R; Gutiérrez A; Gimeno MC; Gatell JM; Sánchez-Merino V; Yuste E; Haro I
Curr Med Chem; 2014; 21(2):238-50. PubMed ID: 24083612
[TBL] [Abstract][Full Text] [Related]
5. GB virus type C interactions with HIV: the role of envelope glycoproteins.
Mohr EL; Stapleton JT
J Viral Hepat; 2009 Nov; 16(11):757-68. PubMed ID: 19758271
[TBL] [Abstract][Full Text] [Related]
6. Synthetic peptides derived from an N-terminal domain of the E2 protein of GB virus C in the study of GBV-C/HIV-1 co-infection.
Fernández L; Chan WC; Egido M; Gómara MJ; Haro I
J Pept Sci; 2012 May; 18(5):326-35. PubMed ID: 22438139
[TBL] [Abstract][Full Text] [Related]
7. Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide.
Herrera E; Gomara MJ; Mazzini S; Ragg E; Haro I
J Phys Chem B; 2009 May; 113(20):7383-91. PubMed ID: 19402654
[TBL] [Abstract][Full Text] [Related]
8. Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.
Herrera E; Tenckhoff S; Gómara MJ; Galatola R; Bleda MJ; Gil C; Ercilla G; Gatell JM; Tillmann HL; Haro I
J Med Chem; 2010 Aug; 53(16):6054-63. PubMed ID: 20718496
[TBL] [Abstract][Full Text] [Related]
9. Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.
Koedel Y; Eissmann K; Wend H; Fleckenstein B; Reil H
J Virol; 2011 Jul; 85(14):7037-47. PubMed ID: 21543477
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected].
Eissmann K; Mueller S; Sticht H; Jung S; Zou P; Jiang S; Gross A; Eichler J; Fleckenstein B; Reil H
PLoS One; 2013; 8(1):e54452. PubMed ID: 23349893
[TBL] [Abstract][Full Text] [Related]
11. HIV entry inhibition by the envelope 2 glycoprotein of GB virus C.
Jung S; Eichenmüller M; Donhauser N; Neipel F; Engel AM; Hess G; Fleckenstein B; Reil H
AIDS; 2007 Mar; 21(5):645-7. PubMed ID: 17314528
[TBL] [Abstract][Full Text] [Related]
12. GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates.
Mohr EL; Xiang J; McLinden JH; Kaufman TM; Chang Q; Montefiori DC; Klinzman D; Stapleton JT
J Immunol; 2010 Oct; 185(7):4496-505. PubMed ID: 20826757
[TBL] [Abstract][Full Text] [Related]
13. Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4⁺ T-cells.
McLinden JH; Stapleton JT; Klinzman D; Murthy KK; Chang Q; Kaufman TM; Bhattarai N; Xiang J
J Gen Virol; 2013 Apr; 94(Pt 4):774-782. PubMed ID: 23288422
[TBL] [Abstract][Full Text] [Related]
14. Characterization of HIV-1 resistance to a fusion inhibitor, N36, derived from the gp41 amino-terminal heptad repeat.
Izumi K; Nakamura S; Nakano H; Shimura K; Sakagami Y; Oishi S; Uchiyama S; Ohkubo T; Kobayashi Y; Fujii N; Matsuoka M; Kodama EN
Antiviral Res; 2010 Aug; 87(2):179-86. PubMed ID: 20438763
[TBL] [Abstract][Full Text] [Related]
15. Surface behavior of peptides from E1 GBV-C protein: Interaction with anionic model membranes and importance in HIV-1 FP inhibition.
Galatola R; Cruz A; Gómara MJ; Prat J; Alsina MA; Haro I; Pujol M
Biochim Biophys Acta; 2015 Feb; 1848(2):392-407. PubMed ID: 25450346
[TBL] [Abstract][Full Text] [Related]
16. Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C.
Sánchez-Martín MJ; Hristova K; Pujol M; Gómara MJ; Haro I; Alsina MA; Busquets MA
J Colloid Interface Sci; 2011 Aug; 360(1):124-31. PubMed ID: 21565353
[TBL] [Abstract][Full Text] [Related]
17. Hydrophobic mutations in buried polar residues enhance HIV-1 gp41 N-terminal heptad repeat-C-terminal heptad repeat interactions and C-peptides' anti-HIV activity.
Zheng B; Wang K; Lu L; Yu F; Cheng M; Jiang S; Liu K; Cai L
AIDS; 2014 Jun; 28(9):1251-60. PubMed ID: 24625369
[TBL] [Abstract][Full Text] [Related]
18. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.
Münch J; Ständker L; Adermann K; Schulz A; Schindler M; Chinnadurai R; Pöhlmann S; Chaipan C; Biet T; Peters T; Meyer B; Wilhelm D; Lu H; Jing W; Jiang S; Forssmann WG; Kirchhoff F
Cell; 2007 Apr; 129(2):263-75. PubMed ID: 17448989
[TBL] [Abstract][Full Text] [Related]
19. Liposome destabilization induced by synthetic lipopeptides corresponding to envelope and non-structural domains of GBV-C/HGV virus. Conformational requirements for leakage.
Fernández-Vidal M; Rojo N; Herrera E; Gómara MJ; Haro I
Biophys Chem; 2008 Jan; 132(1):55-63. PubMed ID: 17988786
[TBL] [Abstract][Full Text] [Related]
20. Peptide Assembly on the Membrane Determines the HIV-1 Inhibitory Activity of Dual-Targeting Fusion Inhibitor Peptides.
Gomara MJ; Perez Y; Martinez JP; Barnadas-Rodriguez R; Schultz A; von Briesen H; Peralvarez-Marin A; Meyerhans A; Haro I
Sci Rep; 2019 Mar; 9(1):3257. PubMed ID: 30824796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
